ArticleBrain and behavior2024

Reversion of chronic to episodic migraine in working age and botulinum toxin-resistant patients treated with fremanezumab: A real-life study.

Juan Tudela-Tomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.